Trading window for dealing in shares of the company shall remain closed for designated persons with effect from 01-10-2025 till 48 hours of declaration of the unaudited financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sampre Nutritions Ltd has informed BSE that the trading window for dealing in its shares will be closed from October 1, 2025 until 48 hours after the company declares its unaudited financial results for the second quarter of FY2025-26 (quarter ending September 30, 2025). During this period, promoters, directors, designated persons, and their immediate relatives are barred from trading in the company's securities. This is a standard compliance measure under SEBI's Prohibition of Insider Trading Regulations. The exact date of the board meeting to approve Q2 results will be announced separately.
This is a routine regulatory compliance filing with no direct impact on shareholders. However, it signals that Sampre Nutritions' Q2 FY26 results are approaching, which investors should monitor for any business updates or earnings surprises.